However, further investigations are needed to evaluate the role of other inhibitory KIR receptors, such as KIR2DL1, KIR3DL1 and KIR3DL2, in anti-leukemia NK cell responses, particularly against AML. The gene discussed is KIR3DL2; the disease is leukemia.